BiotechTube
Home/Avata Biosciences/Jim Gillespie
JG

Jim Gillespie

Program Director

Avata Biosciences

Therapeutic Areas

EpilepsySchizophreniaAddictionNeurologyPsychiatry

Avata Biosciences Pipeline

DrugIndicationPhase
AVAT-021Adult Focal EpilepsyPhase 2
AVAT-021 (Pediatric)Pediatric Focal EpilepsyPreclinical/Phase 1
AVAT-022Pediatric Focal EpilepsyDiscovery/Preclinical
AVAT-031SchizophreniaDiscovery
AVAT-041Opioid Sparing/AddictionDiscovery

Leadership Team at Avata Biosciences

JB
Julian Bryson
Executive Chairman & Cofounder
RH
Rupert Haynes
Chief Executive Officer & Cofounder
DA
Dr. Andrew Saich
Chief Medical Officer & Cofounder
DV
Dr. Venkat Goskonda
Chief Scientific Officer
GP
Grace Powell
Head of Regulatory Affairs
DC
Dr. Chris Hayes
Head of Intellectual Property
DE
Dr. Emma Cheetham
Patent Portfolio Director
View full Avata Biosciences profile